The largest database of trusted experimental protocols

14 protocols using s trityl l cysteine

1

Synchronizing Mitotic HeLa Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mitotic HeLa cells were synchronized in M phase by treating cells with 200 ng/ml nocodazole (Sigma-Aldrich) for 16 h. Cells were then washed and incubated in a proteasome inhibitor, 15 μM MG132 (Sigma-Aldrich), for 3 h followed by collection. For monopolar synchronization, the cells were incubated with an Eg5 inhibitor (5 μM (+)-S-Trityl-L-cysteine (Sigma-Aldrich)) for 16 h and mitotic exit was forced by the addition of 20 μM RO-3306 (Sigma-Aldrich) for 5 min.
+ Open protocol
+ Expand
2

Inducing Lagging Chromosomes and Micronuclei in PtK1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
PtK1, H2B-PAGFP PtK1, and HEC1-GFP PtK1 [32 (link)] cells were cultured in Ham’s F-12 media (Invitrogen) supplemented with 10% Fetal Bovine Serum (Invitrogen), 1 mM sodium pyruvate (Invitrogen), 14 mM sodium bicarbonate (Fisher Scientific), 1% antibiotic-antimycotic (Invitrogen), and maintained at 37° C in a humidified CO2 incubator. For live cell imaging, cells were either grown on glass-bottom dishes and imaged using a stage top incubator (Tokai Hit) or were grown on sterilized coverslips inside 35 mm Petri dishes, transferred into a modified Rose chamber [33 (link)] with top coverslip, and imaged on a microscope stage heated by an air stream incubator (Nevtek). To induce LCs and MNi, cells were incubated in 20 μM STLC (S-Trityl-L-cysteine; Sigma-Aldrich) for 3 hours. The drug was then washed out by rinsing the cells 4 times with warm media. Cells were then re-incubated in fresh Ham’s F-12 media for 24 hours before immunostaining or live-cell imaging. For live-cell imaging, cells were placed in phenol-free L-15 media (Gibco) with 4.5 g/liter glucose. To induce DNA damage, 21 hours after STLC washout, cells were treated with 50 μg/ml Bleocin™ (antibiotic from Streptomyces verticillus; Calbiochem) for 3 hours and then fixed and immunostained as described in the next section.
+ Open protocol
+ Expand
3

Protein Extraction and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were washed with PBS, lysed in RIPA buffer (50 mm Tris/HCl pH 7.4; 1% NP‐40; 0.5% Na‐deoxycholate; 0.1% SDS; 150 mm NaCl, 2 nm EDTA, 50 mm NaF) containing complete protease inhibitor cocktail (Roche, F.Hoffmann‐La Roche Ltd, Basel, Switzerland) for 30 min on ice, and cleared by centrifugation. Protein concentration was determined using Pierce BCA assay kit (Thermo Fisher Scientific Inc.) with a BSA standard curve. Before loading, protein lysates were denatured at 95 °C for 5 min in 6× SDS sample buffer. Proteins were separated by SDS/PAGE on 7.5 or 10% gels before semi‐dry transfer to 0.45 μm nitrocellulose membranes (GE Healthcare, Chalfont St Giles, UK) and blocked in 5% dry milk powder in TBS‐T (100 mm Tris, pH 7.5, 0.9% NaCl, 0.05% Tween‐20). Membranes were incubated with primary antibodies diluted in 5% BSA in TBS‐T at 4 °C over night. After washing in TBS‐T, near‐infrared labeled secondary antibodies (IRDye, Li‐Cor Biosciences, Lincoln, NE, USA, dilution 1 : 5000) were applied for 4 h at room temperature. Images were acquired using Azure c600 fluorescent imager.
Cells for protein extraction for western blots shown in Figs 4C and S6 were synchronized in M phase using 5 μm S‐Trityl‐L‐cysteine (Sigma‐Aldrich) and harvested by mitotic shake off before lysis in RIPA buffer.
+ Open protocol
+ Expand
4

Cell Cycle Regulation Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Where indicated, cells were incubated in 1 μM ICRF193 (Santa Cruz), 1 μM Okadaic acid (Santa Cruz) or 2 μM AZ3146 (Tocris) for 5 min or 10 μM S-trityl-L-cysteine (Sigma) for 20 minutes (Figure 2E, F) or 2h (Figure S3C) before imaging. For RNAi, cells were transfected with 50 nM ON-TARGET plus siRNAs (Dharmacon) targeting RAD21 (AUACCUUCUUGCAGACUGUUU), KIF18A (GCCAAUUCUUCGUAGUUUU), Ska1 (pool targeting: GGACUUACUCGUUAUGUUA, UCAAUGGUGUUCCUUCGUA, UAUAGUGGAAGCUGACAUA and CCGCUUAACCUAUAAUCAA), or a nontargeting control using Lipofectamine RNAi MAX (Invitrogen) following instructions of the manufacturer. Plasmids containing wild type cyclin B1-mCherry or the non-degradable mutant (R42A and L45A) (Gavet and Pines, 2010 (link); Vazquez-Novelle et al., 2014 (link)) were transfected into HeLa cells using Fugene HD (Promega) according to manufacturer’s instructions 24 hours prior to imaging.
+ Open protocol
+ Expand
5

Prostate Cancer Cell Culture and Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
LNCaP and PC3 PCa cells, original from American Type Culture Collection (ATCC), were gifted by Dr. Mu Yao and Prof. Thomas Grewal at the University of Sydney, Australia, respectively. The cell cultures were maintained at 37 °C in a humidified incubator with 5% CO2. All PCa cell lines were cultured in phenol red-free Roswell Park Memorial Institute (RPMI) 1640 medium (Thermo Fisher) containing 10% fetal bovine serum and 1% penicillin/streptomycin. Erianin, bafilomycin A1 and S-trityl-L-cysteine (STLC) were purchased from Sigma, while z-VAD was obtained from BioVision. All treatments were dissolved in dimethyl sulfoxide (DMSO). PC3 cells were transfected with CerS5 and CerS6 plasmids (Genscript) using lipofectamine LTX Plus reagents (Thermo Fisher).
+ Open protocol
+ Expand
6

Cell Synchronization and Chemical Perturbation Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human HeLa Kyoto (HeLa), U2OS and LentiX cells were cultivated in DMEM (Dulbecco's Modified Eagle's Medium; Invitrogen) supplemented with 10% fetal bovine serum (FBS; Gibco) and 1% penicillin/streptomycin (P/S; Gibco). MCF7 cells were cultivated in RPMI (Invitrogen) supplemented with 10% FBS and 1% P/S. hTert‐RPE1 cells were cultivated in DMEM/F12 (Invitrogen) supplemented with 10% FBS, 1% P/S and 0.01 mg/ml Hygromycin B (Sigma). All cell lines were tested negative for mycoplasma contamination. For cell‐cycle synchronization experiments, cells were arrested with 2 mM thymidine for 20 h, then washed three times with medium, and released from the arrest in fresh medium.
To arrest the cells in mitosis, cells were treated with 5 μM S‐Trityl‐L‐cysteine (STLC) (Sigma #164739) or 100 nM PLK1i BI2536 (MedChem) for 22 h, then mitotic cells were collected by shake‐off. For experiments using chemical perturbation, GCN2 (GCN2‐IN‐1 (MedChem)), PERK (GSK2606414 (Calbiochem)), and Aurora A inhibitors (MLN8237 (MedChem)) were added an hour before start of imaging. MPS1 was inhibited with 2µM AZ3146.
+ Open protocol
+ Expand
7

Synthesis and Storage Protocols for Cancer Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The TTK inhibitors NTRC 0066-0 [18 (link)], MPI-0479605 [20 (link)] and Mps-Bay2b [21 (link)] were synthesized according to published protocols. Reversine was purchased from Selleck Chemicals; S-trityl-L-cysteine (STLC) from Sigma Aldrich. The source of all other anti-cancer agents is provided in Supplementary Table 2 of Uitdehaag et al. [41 (link)]. All compounds were stored as powders and freshly dissolved in dimethyl sulfoxide (DMSO) as 10 mM stocks.
+ Open protocol
+ Expand
8

Mitotic Kinase Inhibition and Proteasome Blockade

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mitotic enriched extracts were obtained from parental HeLa cells incubated for 12-16 h in media containing 5 μM of STLC (S-trityl-L-cysteine, Sigma) before harvesting by mitotic shake off. For inhibition of different mitotic kinases the following drugs were used for 1 h at 37ºC: 10 μM RO 3306 (Cdk1 inhibitor, Enzo Life Sciences), 100 nM BI 2536 (Plk1 inhibitor, Axon Medchem), 2 μM ZM 447439 (AurkB inhibitor, AstraZeneca), 5 μM MPS1-IN-1 (Kwiatkowski et al. 2010 (link)) and 40 mM LiCl (GSK3β inhibition). Mitotic exit was blocked with 10 μM of the proteasome inhibitor MG132 (EMD Millipore).
+ Open protocol
+ Expand
9

Cell Cycle Regulation Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Where indicated, cells were incubated in 1 μM ICRF193 (Santa Cruz), 1 μM Okadaic acid (Santa Cruz) or 2 μM AZ3146 (Tocris) for 5 min or 10 μM S-trityl-L-cysteine (Sigma) for 20 minutes (Figure 2E, F) or 2h (Figure S3C) before imaging. For RNAi, cells were transfected with 50 nM ON-TARGET plus siRNAs (Dharmacon) targeting RAD21 (AUACCUUCUUGCAGACUGUUU), KIF18A (GCCAAUUCUUCGUAGUUUU), Ska1 (pool targeting: GGACUUACUCGUUAUGUUA, UCAAUGGUGUUCCUUCGUA, UAUAGUGGAAGCUGACAUA and CCGCUUAACCUAUAAUCAA), or a nontargeting control using Lipofectamine RNAi MAX (Invitrogen) following instructions of the manufacturer. Plasmids containing wild type cyclin B1-mCherry or the non-degradable mutant (R42A and L45A) (Gavet and Pines, 2010 (link); Vazquez-Novelle et al., 2014 (link)) were transfected into HeLa cells using Fugene HD (Promega) according to manufacturer’s instructions 24 hours prior to imaging.
+ Open protocol
+ Expand
10

Inhibition of PLK1 and DNA Damage Response Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies were as follows: p53 (DO-1; Moravian Biotechnology), p21 ((H-164): sc-756; SantaCruz Biotechnology), PLK1 (208G4; Cell Signaling Technology), actin (A2066; Sigma), Poly (ADP-Ribose) Polymerase-1 (PARP) (9542; Cell Signaling Technology), γ-H2AX (Phospho-S139) (ab11174; AbCam), p53 (Phospho-S15) (#9284; Cell Signaling Technology), MDM2 (4B2; Moravian Biotechnology), Gamma-tubulin (T65557; Sigma), Histone H3 ((D1H2): 4499; Cell Signaling Technology), Histone H3 (Phospho-S10) (06–570; Millipore), BrdU Pure ((B44): 347580; Becton Dickinson).
PLK1 inhibitors, GSK461364 and BI6727, ATM and ATR inhibitors, KU-55933 and VE-821, and etoposide were from Selleckchem. The specificity and efficacy of GSK461364 and BI6727 have been described previously36 (link),37 (link). S-Trityl-L-cysteine (STLC) was from Sigma. Taxol was from LC Labs. Nocodazole was from Millipore.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!